Evaluation Of Clinically Important Drug Interactions Involving Angiotensin-Converting Enzyme Inhibitors Among Cardiac Patients [QP609.A53 F219 2008 f rb].

Perencat penukar enzim angiotensin (ACEIs) telah digunakan secara meluas untuk merawat hipertensi dan penyakit kardiovaskular yang lain. Interaksi ubat-ACEI adalah merupakan masalah kesihatan yang signifikan dan perlu penyelidikan lanjut. Angiotensin-converting enzyme inhibitors (ACEIs) are widel...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखक: Amir Abdelkarim Farag, Omalhassan
स्वरूप: थीसिस
भाषा:अंग्रेज़ी
प्रकाशित: 2008
विषय:
QP501-801 Animal biochemistry
ऑनलाइन पहुंच:http://eprints.usm.my/9888/
Abstract Abstract here
_version_ 1854966607961391104
author Amir Abdelkarim Farag, Omalhassan
author_facet Amir Abdelkarim Farag, Omalhassan
author_sort Amir Abdelkarim Farag, Omalhassan
description Perencat penukar enzim angiotensin (ACEIs) telah digunakan secara meluas untuk merawat hipertensi dan penyakit kardiovaskular yang lain. Interaksi ubat-ACEI adalah merupakan masalah kesihatan yang signifikan dan perlu penyelidikan lanjut. Angiotensin-converting enzyme inhibitors (ACEIs) are widely used for the treatment of hypertension and other cardiovascular diseases. ACEIs-drug interaction is a significant health problem that needs further investigations.
first_indexed 2025-10-17T07:56:53Z
format Thesis
id usm-9888
institution Universiti Sains Malaysia
language English
last_indexed 2025-10-17T07:56:53Z
publishDate 2008
record_format eprints
record_pdf Abstract
spelling usm-98882017-03-22T01:59:49Z http://eprints.usm.my/9888/ Evaluation Of Clinically Important Drug Interactions Involving Angiotensin-Converting Enzyme Inhibitors Among Cardiac Patients [QP609.A53 F219 2008 f rb]. Amir Abdelkarim Farag, Omalhassan QP501-801 Animal biochemistry Perencat penukar enzim angiotensin (ACEIs) telah digunakan secara meluas untuk merawat hipertensi dan penyakit kardiovaskular yang lain. Interaksi ubat-ACEI adalah merupakan masalah kesihatan yang signifikan dan perlu penyelidikan lanjut. Angiotensin-converting enzyme inhibitors (ACEIs) are widely used for the treatment of hypertension and other cardiovascular diseases. ACEIs-drug interaction is a significant health problem that needs further investigations. 2008-08 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/9888/1/EVALUATION_OF_CLINICALLY_IMPORTANT_DRUG_INTERACTIONS_INVOLVING_ANGIOTENSIN-CONVERTING_ENZYME_INHIBITORS_AMONG_CARDIAC_PATIENTS.pdf Amir Abdelkarim Farag, Omalhassan (2008) Evaluation Of Clinically Important Drug Interactions Involving Angiotensin-Converting Enzyme Inhibitors Among Cardiac Patients [QP609.A53 F219 2008 f rb]. Masters thesis, Universiti Sains Malaysia.
spellingShingle QP501-801 Animal biochemistry
Amir Abdelkarim Farag, Omalhassan
Evaluation Of Clinically Important Drug Interactions Involving Angiotensin-Converting Enzyme Inhibitors Among Cardiac Patients [QP609.A53 F219 2008 f rb].
title Evaluation Of Clinically Important Drug Interactions Involving Angiotensin-Converting Enzyme Inhibitors Among Cardiac Patients [QP609.A53 F219 2008 f rb].
title_full Evaluation Of Clinically Important Drug Interactions Involving Angiotensin-Converting Enzyme Inhibitors Among Cardiac Patients [QP609.A53 F219 2008 f rb].
title_fullStr Evaluation Of Clinically Important Drug Interactions Involving Angiotensin-Converting Enzyme Inhibitors Among Cardiac Patients [QP609.A53 F219 2008 f rb].
title_full_unstemmed Evaluation Of Clinically Important Drug Interactions Involving Angiotensin-Converting Enzyme Inhibitors Among Cardiac Patients [QP609.A53 F219 2008 f rb].
title_short Evaluation Of Clinically Important Drug Interactions Involving Angiotensin-Converting Enzyme Inhibitors Among Cardiac Patients [QP609.A53 F219 2008 f rb].
title_sort evaluation of clinically important drug interactions involving angiotensin converting enzyme inhibitors among cardiac patients qp609 a53 f219 2008 f rb
topic QP501-801 Animal biochemistry
url http://eprints.usm.my/9888/
work_keys_str_mv AT amirabdelkarimfaragomalhassan evaluationofclinicallyimportantdruginteractionsinvolvingangiotensinconvertingenzymeinhibitorsamongcardiacpatientsqp609a53f2192008frb

समान संसाधन